JP2001506904A5 - - Google Patents

Download PDF

Info

Publication number
JP2001506904A5
JP2001506904A5 JP1998528903A JP52890398A JP2001506904A5 JP 2001506904 A5 JP2001506904 A5 JP 2001506904A5 JP 1998528903 A JP1998528903 A JP 1998528903A JP 52890398 A JP52890398 A JP 52890398A JP 2001506904 A5 JP2001506904 A5 JP 2001506904A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998528903A
Other languages
English (en)
Japanese (ja)
Other versions
JP4153999B2 (ja
JP2001506904A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/023274 external-priority patent/WO1998028037A1/en
Publication of JP2001506904A publication Critical patent/JP2001506904A/ja
Publication of JP2001506904A5 publication Critical patent/JP2001506904A5/ja
Application granted granted Critical
Publication of JP4153999B2 publication Critical patent/JP4153999B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP52890398A 1996-12-20 1997-12-16 経皮作用剤流量を強化するための組成物と方法 Expired - Fee Related JP4153999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3344096P 1996-12-20 1996-12-20
US60/033,440 1996-12-20
PCT/US1997/023274 WO1998028037A1 (en) 1996-12-20 1997-12-16 Device and method for enhancing transdermal agent flux

Publications (3)

Publication Number Publication Date
JP2001506904A JP2001506904A (ja) 2001-05-29
JP2001506904A5 true JP2001506904A5 (enExample) 2005-06-16
JP4153999B2 JP4153999B2 (ja) 2008-09-24

Family

ID=21870407

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52890398A Expired - Fee Related JP4153999B2 (ja) 1996-12-20 1997-12-16 経皮作用剤流量を強化するための組成物と方法

Country Status (11)

Country Link
EP (1) EP0957972B1 (enExample)
JP (1) JP4153999B2 (enExample)
KR (1) KR100453132B1 (enExample)
CN (1) CN1133472C (enExample)
AT (1) ATE234649T1 (enExample)
AU (1) AU722574B2 (enExample)
CA (1) CA2271167C (enExample)
DE (1) DE69720057T2 (enExample)
DK (1) DK0957972T3 (enExample)
ES (1) ES2195190T3 (enExample)
WO (1) WO1998028037A1 (enExample)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024059A1 (en) 1995-12-28 1997-07-10 Cygnus, Inc. Continuous monitoring of physiological analyte
EP1037686B1 (en) 1997-12-11 2005-08-17 Alza Corporation Device for enhancing transdermal agent flux
ATE406935T1 (de) * 1997-12-11 2008-09-15 Alza Corp Vorrichtung zur verbesserung des transdermalen flusses von medikamenten
EP1911488A3 (en) 1997-12-11 2008-12-03 Alza Corporation Device for enhancing transdermal agent flux
US7066884B2 (en) 1998-01-08 2006-06-27 Sontra Medical, Inc. System, method, and device for non-invasive body fluid sampling and analysis
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
CA2341446C (en) * 1998-08-31 2008-10-07 Johnson & Johnson Consumer Companies, Inc. Electrotransport device comprising blades
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
CN1227030C (zh) 1999-04-19 2005-11-16 史密丝克莱恩比彻姆生物有限公司 包含皂甙和免疫刺激寡核苷酸的佐剂组合物
US6558670B1 (en) 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
DE60044084D1 (de) * 1999-06-04 2010-05-12 Georgia Tech Res Inst Vorrichtungen zur vergrösserten penetration von mikronadeln in biologischen hautschichten
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
ATE324922T1 (de) * 1999-06-08 2006-06-15 Altea Therapeutics Corp Vorrichtung zur mikroporation eines biologischen gewebes mittels einer filmgewebe schnittstellenvorrichtung und verfahren
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
AU6076200A (en) 1999-07-08 2001-01-30 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US7133717B2 (en) 1999-08-25 2006-11-07 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery and diagnostic sampling
HK1048604B (en) 1999-12-10 2006-05-04 Alza Corporation Device and method for enhancing microprotrusion skin piercing
HK1048773B (en) * 1999-12-10 2005-10-14 Alza Corporation Skin treatment apparatus for sustained transdermal drug delivery
US6622035B1 (en) * 2000-01-21 2003-09-16 Instrumentarium Corp. Electrode for measurement of weak bioelectrical signals
US7404815B2 (en) 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
US6749575B2 (en) 2001-08-20 2004-06-15 Alza Corporation Method for transdermal nucleic acid sampling
CA2420343A1 (en) * 2000-08-24 2002-02-28 Alza Corporation Method for transdermal nucleic acid sampling
BR0113749A (pt) 2000-09-08 2004-06-22 Alza Corp Métodos para inibir a diminuição no fluxo de droga transdérmica por inibição do fechamento das vias
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
IL155389A0 (en) * 2000-10-13 2003-11-23 Alza Corportion Microprotrusion member retainer for impact applicator
DE60138411D1 (de) * 2000-10-13 2009-05-28 Alza Corp Vorrichtung und verfahren zum durchstechen der haut mit micronadeln
US7419481B2 (en) 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
AU2001296827B2 (en) * 2000-10-13 2005-11-17 Alza Corporation Microblade array impact applicator
US6821281B2 (en) * 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
DK2266603T3 (da) 2000-10-18 2012-11-05 Glaxosmithkline Biolog Sa Tumorvacciner
BR0114909A (pt) 2000-10-26 2004-02-03 Alza Corp Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas
WO2002064193A2 (en) 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
AU2002231207A1 (en) 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
WO2002074173A1 (en) 2001-03-16 2002-09-26 Alza Corporation Method and apparatus for coating skin piercing microprojections
WO2002085447A2 (en) * 2001-04-20 2002-10-31 Alza Corporation Microprojection array having a beneficial agent containing coating
EP1752189A3 (en) 2001-04-20 2007-02-21 Alza Corporation Microprojection array having a beneficial agent containing coating
WO2003024507A2 (en) 2001-09-19 2003-03-27 Biovalve Technologies, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
US8920375B2 (en) 2001-09-21 2014-12-30 Valeritas, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
EP1483019A4 (en) * 2002-03-11 2007-07-04 Altea Therapeutics Corp TRANSDERMALES MEDICAMENT PAVING SYSTEM, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THE APPLICATION THEREOF
AR042815A1 (es) * 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
WO2005004842A2 (en) 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
US8353861B2 (en) 2003-09-18 2013-01-15 Texmac, Inc. Applicator for applying functional substances into human skin
CA2543086A1 (en) * 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
AU2004287412A1 (en) 2003-10-28 2005-05-19 Alza Corporation Method and apparatus for reducing the incidence of tobacco use
AU2004287414B2 (en) 2003-10-31 2010-11-25 Alza Corporation Self-actuating applicator for microprojection array
WO2005051456A2 (en) * 2003-11-13 2005-06-09 Alza Corporation Composition and apparatus for transdermal delivery
WO2005051476A1 (en) * 2003-11-28 2005-06-09 Acrux Dds Pty Ltd Method and system for rapid transdermal administration
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
CN101232874A (zh) * 2004-08-11 2008-07-30 阿尔扎公司 透皮递送利钠肽的装置和方法
JP2008513406A (ja) 2004-09-22 2008-05-01 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
EP1853231A2 (en) * 2005-02-16 2007-11-14 Alza Corporation Apparatus and method for transdermal delivery of erythropoetin-based agents
JP2008534151A (ja) * 2005-03-28 2008-08-28 アルザ コーポレイション 毛管作用制御特徴部を有するマイクロプロジェクション及び方法
JP2008543528A (ja) * 2005-06-27 2008-12-04 スリーエム イノベイティブ プロパティズ カンパニー マイクロニードルカートリッジアセンブリ及び適用方法
US7432069B2 (en) 2005-12-05 2008-10-07 Sontra Medical Corporation Biocompatible chemically crosslinked hydrogels for glucose sensing
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
CN103251940A (zh) 2005-12-22 2013-08-21 葛兰素史密丝克莱恩生物有限公司 疫苗
CA2635251A1 (en) 2005-12-28 2007-07-26 Alza Corporation Stable therapeutic formulations
EP1998802A2 (en) 2006-03-30 2008-12-10 GlaxoSmithKline Biologicals S.A. Immunogenic composition
EP2076312A4 (en) * 2006-04-20 2013-09-04 3M Innovative Properties Co SHAPED ITEMS WITH MICRONADEL ARRANGEMENTS
DE102006028987A1 (de) * 2006-06-24 2007-12-27 Lts Lohmann Therapie-Systeme Ag Ultraschallverstärktes transdermales therapeutisches System
PT2086582E (pt) 2006-10-12 2013-01-25 Glaxosmithkline Biolog Sa Vacina compreendendo uma emulsão adjuvante óleo em água
EP2433648A3 (en) 2006-10-12 2012-04-04 GlaxoSmithKline Biologicals S.A. Vaccine comprising an oil in water emulsion adjuvant
CA2685423C (en) 2007-04-27 2014-02-18 Echo Therapeutics, Inc. Skin permeation device for analyte sensing or transdermal drug delivery
US8747872B2 (en) 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
WO2008139648A1 (ja) 2007-05-15 2008-11-20 Hisamitsu Pharmaceutical Co., Inc. マイクロニードルのコーティング方法
MX2009013949A (es) 2007-06-26 2010-05-24 Glaxosmithkline Biolog Sa Vacuna que comprende conjugados de polisacárido capsular de streptococcus pneumoniae.
CA2745339C (en) 2007-12-24 2016-06-28 The University Of Queensland Coating method
CA2749347C (en) 2008-02-07 2018-03-27 The University Of Queensland Patch production
GB0802447D0 (en) * 2008-02-09 2008-03-19 Univ Manchester Fluid extraction device, associated materials and methods
MX2010011412A (es) 2008-04-16 2010-11-12 Glaxosmithkline Biolog Sa Vacuna.
EP2294415A4 (en) * 2008-05-23 2011-10-05 Univ Queensland DETECTION OF SUBSTANCES TO BE ANALYZED BY A MICRO-NEEDLE STAMPER WITH SELECTIVE REAGENTS
JP5722782B2 (ja) 2008-09-26 2015-05-27 ナノバイオ コーポレーション ナノエマルジョン治療用組成物及びその使用方法
WO2010057197A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
WO2010074239A1 (ja) 2008-12-26 2010-07-01 久光製薬株式会社 マイクロニードルデバイス
EP2392378B1 (en) 2009-01-30 2017-03-15 Hisamitsu Pharmaceutical Co., Inc. Microneedle device
WO2010143689A1 (ja) 2009-06-10 2010-12-16 久光製薬株式会社 マイクロニードルデバイス
BRPI1014031A2 (pt) 2009-06-16 2018-02-20 Univ Michigan Regents vacinas de nanoemulsão
US8696638B2 (en) 2009-07-23 2014-04-15 Hisamitsu Pharmaceutical Co., Inc. Microneedle array
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
CN102770176B (zh) 2010-02-24 2015-11-25 久光制药株式会社 微针装置及其制造方法
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
CN102917751A (zh) 2010-05-28 2013-02-06 久光制药株式会社 具有带有微小突起的阵列的装置
CN102917752A (zh) 2010-05-28 2013-02-06 久光制药株式会社 带微小突起的阵列
US8658603B2 (en) 2010-06-16 2014-02-25 The Regents Of The University Of Michigan Compositions and methods for inducing an immune response
WO2012006677A1 (en) 2010-07-14 2012-01-19 The University Of Queensland Patch applying apparatus
EP2679270B1 (en) 2011-02-24 2016-11-09 Hisamitsu Pharmaceutical Co., Inc. Glp-1 analogue composition for microneedle devices
US8696637B2 (en) * 2011-02-28 2014-04-15 Kimberly-Clark Worldwide Transdermal patch containing microneedles
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
US20140072622A1 (en) 2011-05-17 2014-03-13 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
WO2013055638A1 (en) 2011-10-12 2013-04-18 3M Innovative Properties Company Integrated microneedle array delivery system
AU2012323782B2 (en) 2011-10-12 2017-04-06 Vaxxas Pty Limited Delivery device
JP2013153959A (ja) * 2012-01-30 2013-08-15 Toppan Printing Co Ltd 針状体の構造
CN103356243A (zh) * 2012-03-27 2013-10-23 马广 新型皮肤采样器
BR112015009229B1 (pt) 2012-10-24 2021-07-20 Platelet Targeted Therapeutics, Llc Composição tendo como alvo a expressão de genes para plaquetas, uso de uma célula tronco compreendendo a referida composição para tratar hemofilia e método in vitro ou ex vivo para gerar uma célula tronco modificada
WO2015017561A1 (en) 2013-07-30 2015-02-05 Zosano Pharma, Inc. Low-profile microneedle patch applicator
JP6306700B2 (ja) 2013-11-01 2018-04-04 ユニバーシティ オブ オスロUniversity of Oslo アルブミン改変体及びその使用
CA2929126C (en) 2013-11-13 2020-01-07 University Of Oslo Outer membrane vesicles and uses thereof
US11452767B2 (en) 2013-11-15 2022-09-27 Oslo Universitetssykehus Hf CTL peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof
WO2016057921A1 (en) 2014-10-10 2016-04-14 Baker Jr James R Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
MA40920A (fr) 2014-11-07 2017-09-12 Takeda Vaccines Inc Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
AR102548A1 (es) 2014-11-07 2017-03-08 Takeda Vaccines Inc Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y uso
US11147954B2 (en) 2015-02-02 2021-10-19 Vaxxas Pty Limited Microprojection array applicator and method
EP4226937A3 (en) 2015-03-05 2023-09-27 Northwestern University Non-neuroinvasive viruses and uses thereof
US11103259B2 (en) 2015-09-18 2021-08-31 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
EP3355981B1 (en) 2015-09-28 2025-11-19 Vaxxas Pty Limited Microprojection arrays with enhanced skin penetrating properties and methods thereof
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
EP3454891A4 (en) 2016-05-10 2019-12-25 The Regents of The University of Michigan EMULSION ADJUVANS FOR INTRAMUSCULAR, INTRADERMAL AND SUBCUTANEOUS ADMINISTRATION
WO2017201390A1 (en) 2016-05-19 2017-11-23 The Regents Of The University Of Michigan Novel adjuvant compositions
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
WO2018096396A1 (en) 2016-11-22 2018-05-31 University Of Oslo Albumin variants and uses thereof
CN110114069B (zh) 2016-12-26 2022-03-04 久光制药株式会社 微针装置
KR102343698B1 (ko) 2017-02-24 2021-12-24 히사미쓰 세이야꾸 가부시키가이샤 마이크로니들 디바이스
AU2018241251B2 (en) 2017-03-31 2024-06-27 Vaxxas Pty Limited Device and method for coating surfaces
US11175128B2 (en) 2017-06-13 2021-11-16 Vaxxas Pty Limited Quality control of substrate coatings
CN111065417B (zh) 2017-06-23 2024-04-19 美商艾芬尼维克斯公司 免疫原性组合物
CA3071680A1 (en) 2017-08-04 2019-02-07 Vaxxas Pty Limited Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (map)
EP3678698A1 (en) 2017-09-07 2020-07-15 University Of Oslo Vaccine molecules
US12005112B2 (en) 2017-09-07 2024-06-11 University Of Oslo Vaccine molecules
CA3081581A1 (en) 2017-11-03 2019-05-09 Takeda Vaccines, Inc. Method for inactivating zika virus and for determining the completeness of inactivation
GB201721576D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa Hla antigens and glycoconjugates thereof
GB201721582D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa S aureus antigens and immunogenic compositions
US12233156B2 (en) 2018-06-26 2025-02-25 Hisamitsu Pharmaceutical Co., Inc. Microneedle device and method for producing the same
WO2021206294A1 (ko) * 2020-04-06 2021-10-14 (주)일론 화장품 흡수 유도용 미세바늘이 장착된 화장품 주입기 및 이의 제작방법
US20230233667A1 (en) 2021-09-08 2023-07-27 Affinivax, Inc. Coronavirus vaccine
EP4705319A1 (en) 2023-05-04 2026-03-11 Affinivax, Inc. Rhizavidin variants
WO2025193903A1 (en) 2024-03-15 2025-09-18 Affinivax, Inc. Pneumococcal polysaccharide compositions and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
ES2082973T3 (es) 1990-03-30 1996-04-01 Alza Corp Dispositivo para administracion iontoforetica de farmacos.
MX9101782A (es) 1990-10-29 1992-06-05 Alza Corp Dispositivo de suministro iontoforetico y metodo para hidratar el mismo
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
AU4256496A (en) * 1994-12-09 1996-06-26 Novartis Ag Transdermal system
AU5869796A (en) * 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
DE19525607A1 (de) * 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem

Similar Documents

Publication Publication Date Title
JP2000515782A5 (enExample)
JP2000504599A5 (enExample)
JP2001502699A5 (enExample)
JP2001508320A5 (enExample)
JP2000506629A5 (enExample)
JP2001508144A5 (enExample)
JP2001507951A5 (enExample)
JP2001501503A5 (enExample)
JP2001502058A5 (enExample)
JP2000513721A5 (enExample)
JP2001504173A5 (enExample)
JP2001503253A5 (enExample)
JP2001505892A5 (enExample)
JP2001507350A5 (enExample)
JP2000507544A5 (enExample)
JP2001502689A5 (enExample)
JP2000516526A5 (enExample)
JP2000508575A5 (enExample)
JP2000507722A5 (enExample)
JP2000515040A5 (enExample)
JP2000515401A5 (enExample)
JP2000503912A5 (enExample)
JP2000505632A5 (enExample)
JP2000512427A5 (enExample)
JP2001502421A5 (enExample)